Acurx Pharmaceuticals shares drop approximately 34% ahead of Q3 earnings release
ACXP Acurx Pharmaceuticals Inc
$1.06 0.00%
View chart & analysis → - 1Acurx Pharmaceuticals shares have recorded a decline of approximately 34% since the last report.
- 2Wall Street expects a projected loss of $0.45 per share for the third quarter.
- 3Acurx Pharmaceuticals will begin Pathfinder study enrollment for 20 patients in the fourth quarter.
So what's the key point?
Acurx Pharmaceuticals shares have fallen by about 34 percent since the last report. Experts expect a loss of $0.45 per share this quarter.
Source Earnings Whispers · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.